 |
antimesothelin-ADC (antibody drug conjugate) |
|---|---|
| Trade Name | |
| Orphan Indication | Malignant pleural mesothelioma |
| USA Market Approval | USA |
| USA Designation Date | 2012-07-05 00:00:00 |
| Sponsor | Bayer HealthCare Pharmaceuticals, Inc.;340 Changebridge Road;Pine Brook, New Jersey, 07058 |
